Sector 10, Inc. (SECI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 7036.00 USD | -98.66% |
| 2022 | 524.72 Thousand USD | -74.02% |
| 2021 | 2.01 Million USD | 207.18% |
| 2020 | -1.88 Million USD | -44.36% |
| 2019 | -1.3 Million USD | -6.9% |
| 2018 | -1.22 Million USD | -0.17% |
| 2017 | -1.21 Million USD | -7.2% |
| 2016 | -1.13 Million USD | -5.84% |
| 2015 | -1.07 Million USD | -7.68% |
| 2014 | -997.8 Thousand USD | -3.59% |
| 2013 | -963.19 Thousand USD | 33.46% |
| 2012 | -1.44 Million USD | 43.73% |
| 2011 | -2.57 Million USD | 43.93% |
| 2010 | -4.58 Million USD | -761.08% |
| 2009 | -532.77 Thousand USD | -329.84% |
| 2008 | -123.94 Thousand USD | 96.03% |
| 2007 | -3.11 Million USD | -126.57% |
| 2006 | -1.37 Million USD | 13.56% |
| 2005 | -1.59 Million USD | -68.99% |
| 2004 | -942.35 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | -6680.00 USD | -35.28% |
| 2024 Q2 | -4938.00 USD | -30.22% |
| 2024 Q1 | -3792.00 USD | 89.7% |
| 2023 Q2 | -6288.00 USD | -27.68% |
| 2023 Q3 | 55.06 Thousand USD | 975.67% |
| 2023 Q4 | -36.81 Thousand USD | -166.86% |
| 2023 FY | 7036.00 USD | -98.66% |
| 2023 Q1 | -4925.00 USD | 99.1% |
| 2022 Q4 | -546.18 Thousand USD | -5109.69% |
| 2022 Q1 | -18.46 Thousand USD | -107.34% |
| 2022 Q2 | 564.64 Thousand USD | 3158.43% |
| 2022 FY | 524.72 Thousand USD | -74.02% |
| 2022 Q3 | -10.48 Thousand USD | -101.86% |
| 2021 FY | 2.01 Million USD | 207.18% |
| 2021 Q1 | -349.48 Thousand USD | 4.89% |
| 2021 Q2 | -279.13 Thousand USD | 20.13% |
| 2021 Q3 | 1.83 Million USD | 758.7% |
| 2021 Q4 | 251.41 Thousand USD | -86.33% |
| 2020 Q1 | -334.57 Thousand USD | -0.78% |
| 2020 Q4 | -367.44 Thousand USD | -10.79% |
| 2020 Q3 | -331.67 Thousand USD | -2.19% |
| 2020 FY | -1.88 Million USD | -44.36% |
| 2020 Q2 | -324.57 Thousand USD | 2.99% |
| 2019 Q1 | -319.43 Thousand USD | -1.13% |
| 2019 FY | -1.3 Million USD | -6.9% |
| 2019 Q4 | -331.96 Thousand USD | -1.19% |
| 2019 Q3 | -328.05 Thousand USD | -0.66% |
| 2019 Q2 | -325.91 Thousand USD | -2.03% |
| 2018 Q1 | -298.07 Thousand USD | 2.22% |
| 2018 FY | -1.22 Million USD | -0.17% |
| 2018 Q4 | -315.87 Thousand USD | -3.68% |
| 2018 Q3 | -304.67 Thousand USD | -0.71% |
| 2018 Q2 | -302.51 Thousand USD | -1.49% |
| 2017 Q1 | -273.95 Thousand USD | 5.82% |
| 2017 FY | -1.21 Million USD | -7.2% |
| 2017 Q4 | -304.84 Thousand USD | 8.41% |
| 2017 Q3 | -332.83 Thousand USD | -8.26% |
| 2017 Q2 | -307.44 Thousand USD | -12.23% |
| 2016 FY | -1.13 Million USD | -5.84% |
| 2016 Q3 | -284.43 Thousand USD | -0.24% |
| 2016 Q2 | -283.76 Thousand USD | -2.03% |
| 2016 Q4 | -290.89 Thousand USD | -2.27% |
| 2016 Q1 | -278.11 Thousand USD | 0.25% |
| 2015 Q4 | -278.81 Thousand USD | -9.64% |
| 2015 Q2 | -273 Thousand USD | -1.73% |
| 2015 FY | -1.07 Million USD | -7.68% |
| 2015 Q1 | -268.36 Thousand USD | -4.11% |
| 2015 Q3 | -254.3 Thousand USD | 6.85% |
| 2014 Q1 | -241.35 Thousand USD | 5.24% |
| 2014 FY | -997.8 Thousand USD | -3.59% |
| 2014 Q2 | -248.98 Thousand USD | -3.16% |
| 2014 Q3 | -249.7 Thousand USD | -0.29% |
| 2014 Q4 | -257.76 Thousand USD | -3.23% |
| 2013 FY | -963.19 Thousand USD | 33.46% |
| 2013 Q4 | -254.69 Thousand USD | 5.68% |
| 2013 Q3 | -270.03 Thousand USD | -7.75% |
| 2013 Q2 | -250.62 Thousand USD | -33.43% |
| 2013 Q1 | -187.83 Thousand USD | 77.63% |
| 2012 Q1 | -250.33 Thousand USD | 60.68% |
| 2012 FY | -1.44 Million USD | 43.73% |
| 2012 Q4 | -839.52 Thousand USD | -392.15% |
| 2012 Q3 | -170.58 Thousand USD | 8.8% |
| 2012 Q2 | -187.05 Thousand USD | 25.28% |
| 2011 FY | -2.57 Million USD | 43.93% |
| 2011 Q4 | -636.71 Thousand USD | 32.95% |
| 2011 Q3 | -949.59 Thousand USD | -49.26% |
| 2011 Q2 | -636.19 Thousand USD | -81.79% |
| 2011 Q1 | -349.95 Thousand USD | 89.74% |
| 2010 Q4 | -3.41 Million USD | -693.04% |
| 2010 FY | -4.58 Million USD | -761.08% |
| 2010 Q1 | -420.69 Thousand USD | 23.3% |
| 2010 Q2 | -324.42 Thousand USD | 22.88% |
| 2010 Q3 | -430.27 Thousand USD | -32.63% |
| 2009 Q2 | -135.14 Thousand USD | -149.37% |
| 2009 Q3 | -122.89 Thousand USD | 9.06% |
| 2009 FY | -532.77 Thousand USD | -329.84% |
| 2009 Q4 | -548.47 Thousand USD | -346.28% |
| 2009 Q1 | 273.74 Thousand USD | 520.49% |
| 2008 Q1 | -818.66 Thousand USD | -160.04% |
| 2008 FY | -123.94 Thousand USD | 96.03% |
| 2008 Q4 | -65.1 Thousand USD | -10.63% |
| 2008 Q3 | -58.84 Thousand USD | 92.81% |
| 2008 Q2 | -818.66 Thousand USD | 0.0% |
| 2007 Q2 | -636.8 Thousand USD | -46.89% |
| 2007 Q4 | 1.36 Million USD | 139.96% |
| 2007 FY | -3.11 Million USD | -126.57% |
| 2007 Q1 | -433.53 Thousand USD | -80.18% |
| 2007 Q3 | -3.41 Million USD | -435.77% |
| 2006 FY | -1.37 Million USD | 13.56% |
| 2006 Q4 | -240.61 Thousand USD | 20.08% |
| 2006 Q3 | -301.05 Thousand USD | 14.5% |
| 2006 Q2 | -352.12 Thousand USD | 27.06% |
| 2006 Q1 | -482.73 Thousand USD | -24.29% |
| 2005 Q2 | -449.09 Thousand USD | -31.04% |
| 2005 FY | -1.59 Million USD | -68.99% |
| 2005 Q1 | -342.71 Thousand USD | 63.54% |
| 2005 Q4 | -388.41 Thousand USD | 5.88% |
| 2005 Q3 | -412.66 Thousand USD | 8.11% |
| 2004 FY | -942.35 Thousand USD | 0.0% |
| 2004 Q4 | -940.08 Thousand USD | -384.58% |
| 2004 Q2 | -286.11 Thousand USD | -12476.53% |
| 2004 Q3 | -193.99 Thousand USD | 32.2% |
| 2004 Q1 | -2275.00 USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| American Medical Technologies Inc. | -926.89 Thousand USD | 100.759% |
| Ansell Limited | 76.5 Million USD | 99.991% |
| Ansell Limited | 76.5 Million USD | 99.991% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 24.28 Million USD | 99.971% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.63 Million USD | 100.432% |
| Psykey, Inc. | -1.32 Million USD | 100.531% |
| ConvaTec Group Plc | 130.3 Million USD | 99.995% |
| ConvaTec Group Plc | 130.3 Million USD | 99.995% |
| Encision Inc. | -691.78 Thousand USD | 101.017% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 104.962% |
| Hear AtLast Holdings, Inc. | -234.36 Thousand USD | 103.002% |
| Innovative MedTech Inc. | -7.93 Million USD | 100.089% |
| LifePoint, Inc. | -15.23 Million USD | 100.046% |
| Medite Cancer Diagnostics, Inc. | -6.81 Million USD | 100.103% |
| Paradigm Medical Industries, Inc. | -474 Thousand USD | 101.484% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -274.44 Thousand USD | 102.564% |
| Reflect Scientific, Inc. | -459.02 Thousand USD | 101.533% |
| SmileDirectClub, Inc. | -86.4 Million USD | 100.008% |
| Shandong Weigao Group Medical Polymer Company Limited | 2 Billion USD | 100.0% |
| SheerVision, Inc. | -71.37 Thousand USD | 109.858% |
| United Health Products, Inc. | -2.62 Million USD | 100.268% |
| Vasamed, Inc. | -4.88 Million USD | 100.144% |
| Wearable Health Solutions, Inc. | -2.38 Million USD | 100.295% |
| Yubo International Biotech Limited | -1.2 Million USD | 100.584% |